Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Maintains Hold Rating Ahead of lululemon athletica (LULU) Q1 Results
-
Canaccord Genuity Cuts Price Target on Sierra Wireless (SWIR) Following Investor Meeting
-
Canaccord Genuity Raised Price Target After Meeting with Cavium (CAVM) CEO
-
Minera IRL Announces US$70 Million Bridge Loan and Mandate Letter for Up to US$240 Million for Ollachea Project Financing
-
Amana Copper Ltd. Announces Transaction With International Wastewater Systems
-
Vertex Pharma (VRTX) to Collaborate with Parion on ENaC Inhibitors; Canaccord Genuity Maintains Buy
-
Ultragenyx Pharma (RARE) PT Raised to $97 at Canaccord Genuity
-
Canaccord Genuity Raised Price Target on Cyberonics (CYBX) Ahead of Sorin Group Merger
-
UPDATE: Palatin Technologies' (PTN) Price Target Raised to $6 at Canaccord Genuity Amid Flibanserin FDA Panel Backing
-
Canaccord Genuity Maintains Buy on Mentor Graphics (MENT) Ahead of Meetings
-
Intersect ENT (XENT) Prices Larger 3.58M Common Offering at $25/Share
-
Canaccord Genuity Reiterates Buy on Derma Sciences (DSCI) Believing Timeline Confusion Created Buying Opportunity
-
Ambarella (AMBA) PT Raised to $115 at Canaccord Genuity
-
Cowen Expands Energy Equity Research Team with Addition of Ryan Oatman
-
Intersect ENT Announces Upsizing and Pricing of Public Offering
-
Canaccord Genuity Group Inc. Reports Record Annual Revenue for 2015
-
Nighthawk Energy plc ("Nighthawk" or "the Company") Final Results for the year ended 31 December 2014
-
Canaccord Genuity Raises Price Target on TTM Technologies (TTMI) Following Viasystems Acquisition
-
UPDATE: Canaccord Genuity Starts HTG Molecular Diagnostics (HTGM) at Buy
-
Canaccord Genuity Maintains Bullish View on Alnylam (ALNY) Amid Positive KOL Insights on ALN-CC5
-
Enterprise Mobility Leader Globo Begins Trading on the OTCQX International Exchange in the U.S.
-
Intersect ENT (XENT) Commences 3M Common Stock Offering
-
Intersect ENT Commences Public Offering
-
Immunogen (IMGN) PT Lifted to $20 at Canaccord Genuity Following IMGN853 ASCO Data
-
Hologic (HOLX) PT Boosted to $40 at Canaccord Genuity Following Meetings
-
Canaccord Genuity Raised Price Target Following Investor Meetings with Skyworks Solutions (SWKS)
-
Canaccord Genuity Raises Price Target on ePlus (PLUS) Following Q4 Results
-
North American Financial 15 Split Corp. Announces Successful Overnight Offering
-
Avago (AVGO) PT Raised to $170 at Canaccord Genuity Amid Broadcom (BRCM) Deal
-
Orsu Metals Corporation: Notice of Annual Shareholder Meeting and Posting of Circular
-
North American Financial 15 Split Corp. Announces Overnight Offering
-
Notable Analyst Rating Changes 5/28: (RL) (JCI) (GM) Upgraded; (BT) (BONT) (TFM) Downgraded
-
Canaccord Genuity Strengthens Global Healthcare and Technology Capability with Addition of Key Investment Banking and Research Professionals
-
Canaccord Genuity Reiterates Buy Ahead of Deckers Outdoor (DECK) Q4 Results
-
Canaccord Genuity Cuts Price Target on Michael Kors (KORS) Following Q4
-
Canaccord Genuity Raised Price Target on SolarEdge Technologies (SEDG) Following Investor Meetings
-
Dividend 15 Split Corp. Completes Overnight Offering of $94,170,000
-
Canaccord Genuity Downgrades Magnum Hunter (MHR) to Hold
-
Seres Therapeutics (MCRB) Files for $100M IPO
-
Shopify Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option
-
Shopify Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option
-
Canaccord Genuity Reiterate Buy Following Workday (WDAY) Q1
-
Notable 52-Week Highs and Lows 5/26: (CVC) (DE) (PANW) High; (ACI) (ANR) (KORS) Low
-
Canaccord Genuity Raised Price Target on Foot Locker (FL) Following Q1 Results
-
Canaccord Genuity Cuts Price Target to $63 on Michael Kors (KORS) Following Industry Checks
-
AirXpanders Announces Initial Public Offering in Australia
-
ProMetic Announces the Exercise of the Over-Allotment Option Under Its Bought Deal Offering of Common Shares
-
Revolutionary US Medical Device Company AirXpanders to List on ASX
-
Aldeyra Therapeutics Announces Closing of Common Stock Offering
-
Unusual 11 Mid-Day Movers 5/22: (ABTL) (ONTY) (RWLK) Higher; (OTIC) (CNIT) (VGGL) Lower

